Guideline Profile : Psoriasis
You are here : Home > Formulary Search > Guideline Profile : Psoriasis
Documentation
Guidelines (Local)
Guidelines (National)
Guidelines (National)
Policy Statement
Drugs
Below are listed all drugs that are used to treat Psoriasis.
Committee Recommendations (3)
04 Aug 26 -
Surrey & Sussex Area Prescribing Committee (APC)
The APC agreed to adopt the SERMOG position statement in relation to the use of high-cost drugs in the treatment of localised psoriasis.
The Surrey Heartland Integrated Care System Area Prescribing Committee have agreed to adopt the SERMOG high-cost drugs pathway.for adiults with psoriasis
The Surrey Heartlands APC support the use of national guidance in the management of psoriasis in Primary Care.
Links have been provided to NICE/CKS guidance and resources from the Primary Care Dermatology Society (see documents)
Guideline Profile
Indication :
Psoriasis
Keywords :
Psoriderm, exorex, coal tar, lecithin, polytar, alphosyl, T/Gel, calcipotriol, dalonev, dovobet, Enstilar, Silkis tacalcitol,psorin, bettamousse
Cocois/sebco, capasal
hydrocortisone, dermacort
alclometasone, clobetasol
betamethasone, mometasone
clobetasone, diflucortolone
fluocinonide, fluticasone
fluocinolone
fludroxycotide
Brand Names Include :
Important Information :
Latest Additions Date From :
21 Nov 2025
Latest Additions Date To :
21 Dec 2025
Supporting Documents :
5